J Thromb Haemost 2018 May 08
Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH.
Related Questions
Is there a preferred strategy of transfusional support versus reduced-dose anticoagulation during the duration of thrombocytopenia?
New answer by at University of Washington School of Medicine (November 9, 2020)
The thrombosis versus bleeding risk ratio should be weighed. The risk of VTE recurrence or propagation is highest in the first 30 days and we know that thrombocytopenia does n...